Loading...
Anti-CD45RB Antibody Therapy Attenuates Renal Ischemia-Reperfusion Injury by Inducing Regulatory B Cells
BACKGROUND: Regulatory B cells are a newly discovered B cell subset that suppresses immune responses. Recent studies found that both anti-CD45RB and anti–Tim-1 treatments regulate immune responses by inducing regulatory B cells; however, the role of these cells in renal ischemia-reperfusion injury (...
Na minha lista:
| Udgivet i: | J Am Soc Nephrol |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society of Nephrology
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6779371/ https://ncbi.nlm.nih.gov/pubmed/31296607 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2018101067 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|